Expression of activation markers on decidual and peripheral blood CD4+ T cells, CD8+ T cells, and CD16−CD56bright NK cells
| Decidua | Peripheral blood | |
|---|---|---|
| % of positive cells (mean ± SD) | % of positive cells (mean ± SD) | |
| CD4+ T cells | ||
| IL-2Rα (CD25) | 26.9 ± 5.0 | 20.5 ± 5.2 |
| IL-2Rβ (CD122) | 8.6 ± 4.6 | 1.5 ± 0.5 |
| CD69 | 58.3 ± 12.7 | 0.9 ± 0.5 |
| HLA-DR | 67.7 ± 14.8 | 11.8 ± 4.7 |
| CD8+ T cells | ||
| IL-2Rα (CD25) | 6.2 ± 2.9 | 2.5 ± 1.5 |
| IL-2Rβ (CD122) | 17.7 ± 7.2 | 10.6 ± 3.4 |
| CD69 | 73.3 ± 14.3 | 3.5 ± 0.7 |
| HLA-DR | 82.9 ± 13.5 | 20.6 ± 7.4 |
| CD16−CD56bright NK cells | ||
| CD69 | 58.4 ± 11.3 | 0.07 ± 0.03 |
| HLA-DR | 11.3 ± 4.5 | 0.7 ± 0.2 |
SD: standard deviation
Note. Adapted from “Accumulation of CD16−CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.” by Nishikawa K, Saito S, Morii T, Hamada K, Ako H, Narita N, et al. Int Immunol. 1991;3:743–50 (https://academic.oup.com/intimm/article-lookup/doi/10.1093/intimm/3.8.743). © 1991 Oxford University Press;
“Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2Rα) and IL-2Rβ on T cells of human decidua at an early stage of pregnancy.” by Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ichijo M. Immunology. 1992;75:710–2 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1384855). © 1992 Wiley Online Library.